Here is who you can expect to meet May 18-20, 2021


Attendees as of April 16, 2021

Title/Department/Company

Sr Director & Early Dev Team Leader, Product & Portfolio Management, Aimmune Therapeutics Inc

Sr Director Business Planning & Analysis, Business Planning & Analysis, Alnylam Pharmaceuticals

Exec Director Business Performance, Business Performance, Amgen Inc

Director Business Performance, Business Perfeormance, Amgen Inc

COO, Asieris Pharmaceuticals

Exec Director, Association of Clinical Research Professionals

Director Program Management, Preclinical Dev, Axcella Health

Sr Portfolio Manager, Global Portfolio Management, Bayer AG

Sr Manager, Program & Portfolio Management, bluebird bio

Head Strategy & Operations, Business Insights & Analytics & R&D, Bristol Myers Squibb Co

Director Early Dev Project Management, R&D Strategy & Planning, Bristol Myers Squibb Co

Head, Marketing, Captario AB

Portfolio Manager, Portfolio, CEPI

Director Portfolio Management & Governance, Portfolio Management & Governance, CSL Behring

Sr Director Project & Portfolio Management, Daiichi Sankyo Inc

Sr Director Global External R&D Due Diligence, Global External R&D Due Diligence, Eli Lilly & Co

Sr Director LRL Project Management R&D, LRL Project Management R&D, Eli Lilly & Co

Director Project Management, Integrated Oncology Strategy and Operations, Genmab US Inc

Sr Director Strategy & Portfolio, Consumer Healthcare R&D, GlaxoSmithKline Consumer Health

Manager & Team Leader, Research Planning, Green Cross R&D Ctr

Director & Consultant, Risk Based Approach Ltd, Risk Based Approach Ltd

Assoc Director Project Management, Project Management, Janssen Pharmaceuticals Inc

Sr Manager, CMC Management & Strategy & Business Operations, Kite a Gilead Co

VP Corp Dev & Portfolio Strategy, Corp Dev & Portfolio Strategy, Lava Therapeutics

Innovation Portfolio Manager, Research Strategy & Innovation, Mallinckrodt Pharmaceuticals

Assoc VP & Regional Head, Global Clinical Trial Operations, Merck

Exec Director Portfolio Prioritization, Global Regulatory Affairs & Clinical Safety, Merck & Co

Sr Director, R&D Portfolio Management, Novo Nordisk AS

Director Research Portfolio Analysis, WRDM Operations, Pfizer Inc

Director Project Management, Poseida Therapeutics Inc

Sr Director Project Management, Poseida Therapeutics Inc

Exec Director Drug Dev, PRA Health Sciences

President & Founder, Project & Portfolio Value Creation

Manager, Samsung Bioepis

Sr Director Bus Dev, Samyang Biopharm USA Inc

Director Project Portfolio, Project Portfolio, Sanofi

President & CEO, Velocity Clinical Research

Head, Program & Alliance Management, Vor Biopharma Inc

Assoc Principal, ZS Associates

Sr Marketing Assoc, Event Marketing, ZS Associates

Assoc Principal, ZS Associates

Principal, ZS Associates Inc

Consultant, Strategy Insights & Planning, ZS Associates Inc



For questions about this year's event, please contact:

Bridget Kotelly
Conference Producer
Cambridge Healthtech Institute (CHI)
T: (+1) 781-972-5404